James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Twitter Inc. (TWTR), Goldcorp Inc. (GG) and NXP Semiconductors NV (NXPI) Are 3 of Today’s Worst Stocks

Twitter (TWTR), Goldcorp (GG) and NXP Semiconductors (NXPI) sucker-punched shareholders on Thursday. Here's the deal.

PayPal Stock Isn’t as Bulletproof as Once Thought

The spinoff of PayPal stock from eBay may not have been the game-changing, "value unlocking" event it was billed to be.

AMGN Looks Compelling After Earnings, Despite Brewing Headwinds

The Amgen earnings report for Q3 reinvigorated AMGN shares, for all the right reasons.

Why Gilead Sciences, Inc. (GILD), Akamai Technologies, Inc. (AKAM) and Walgreens Boots Alliance Inc (WBA) Are 3 of Today’s Worst Stocks

Gilead Sciences (GILD), Akamai Technologies (AKAM) and Walgreens Boots Alliance (WBA) were all suspiciously omitted from today's marketwide rally.

Here’s Why Amazon Stock Holders Should Start to Worry (AMZN)

Amazon has made some dumb decisions in the past, but it's boneheaded attempt at fashion is vying for the No. 1 dumbest move in AMZN history.